Literature DB >> 22888139

Protective role of commensals against Clostridium difficile infection via an IL-1β-mediated positive-feedback loop.

Mizuho Hasegawa1, Nobuhiko Kamada, Yizu Jiao, Meng Zhen Liu, Gabriel Núñez, Naohiro Inohara.   

Abstract

Clostridium difficile is a Gram-positive obligate anaerobic pathogen that causes pseudomembranous colitis in antibiotic-treated individuals. Commensal bacteria are known to have a significant role in the intestinal accumulation of C. difficile after antibiotic treatment, but little is known about how they affect host immunity during C. difficile infection. In this article, we report that C. difficile infection results in translocation of commensals across the intestinal epithelial barrier that is critical for neutrophil recruitment through the induction of an IL-1β-mediated positive-feedback loop. Mice lacking ASC, an essential mediator of IL-1β and IL-18 processing and secretion, were highly susceptible to C. difficile infection. ASC(-/-) mice exhibited enhanced translocation of commensals to multiple organs after C. difficile infection. Notably, ASC(-/-) mice exhibited impaired CXCL1 production and neutrophil influx into intestinal tissues in response to C. difficile infection. The impairment in neutrophil recruitment resulted in reduced production of IL-1β and CXCL1 but not IL-18. Importantly, translocated commensals were required for ASC/Nlrp3-dependent IL-1β secretion by neutrophils. Mice lacking IL-1β were deficient in inducing CXCL1 secretion, suggesting that IL-1β is the dominant inducer of ASC-mediated CXCL1 production during C. difficile infection. These results indicate that translocated commensals play a crucial role in CXCL1-dependent recruitment of neutrophils to the intestine through an IL-1β/NLRP3/ASC-mediated positive-feedback mechanism that is important for host survival and clearance of translocated commensals during C. difficile infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22888139      PMCID: PMC3752782          DOI: 10.4049/jimmunol.1200821

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome.

Authors:  Jeffrey Ng; Simon A Hirota; Olaf Gross; Yan Li; Annegret Ulke-Lemee; Mireille S Potentier; L Patrick Schenck; Akosua Vilaysane; Mark E Seamone; Hanping Feng; Glen D Armstrong; Jurg Tschopp; Justin A Macdonald; Daniel A Muruve; Paul L Beck
Journal:  Gastroenterology       Date:  2010-04-13       Impact factor: 22.682

2.  Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen.

Authors:  Mizuho Hasegawa; Takashi Yamazaki; Nobuhiko Kamada; Kazuki Tawaratsumida; Yun-Gi Kim; Gabriel Núñez; Naohiro Inohara
Journal:  J Immunol       Date:  2011-03-16       Impact factor: 5.422

Review 3.  The host immune response to Clostridium difficile.

Authors:  Ciarán P Kelly; Lorraine Kyne
Journal:  J Med Microbiol       Date:  2011-03-17       Impact factor: 2.472

4.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

5.  The role of toxin A and toxin B in Clostridium difficile infection.

Authors:  Sarah A Kuehne; Stephen T Cartman; John T Heap; Michelle L Kelly; Alan Cockayne; Nigel P Minton
Journal:  Nature       Date:  2010-09-15       Impact factor: 49.962

6.  Nod1 ligands induce site-specific vascular inflammation.

Authors:  Hisanori Nishio; Shunsuke Kanno; Sagano Onoyama; Kazuyuki Ikeda; Tamami Tanaka; Koichi Kusuhara; Yukari Fujimoto; Koichi Fukase; Katsuo Sueishi; Toshiro Hara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-02-17       Impact factor: 8.311

7.  Transitions in oral and intestinal microflora composition and innate immune receptor-dependent stimulation during mouse development.

Authors:  Mizuho Hasegawa; Toshifumi Osaka; Kazuki Tawaratsumida; Takashi Yamazaki; Hiroyuki Tada; Grace Y Chen; Satoshi Tsuneda; Gabriel Núñez; Naohiro Inohara
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

Review 8.  Clostridium difficile infection: new developments in epidemiology and pathogenesis.

Authors:  Maja Rupnik; Mark H Wilcox; Dale N Gerding
Journal:  Nat Rev Microbiol       Date:  2009-07       Impact factor: 60.633

9.  A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins.

Authors:  Anthony Ryan; Mark Lynch; Sinead M Smith; Sylvie Amu; Hendrik J Nel; Claire E McCoy; Jennifer K Dowling; Eve Draper; Vincent O'Reilly; Ciara McCarthy; Julie O'Brien; Déirdre Ní Eidhin; Mary J O'Connell; Brian Keogh; Charles O Morton; Thomas R Rogers; Padraic G Fallon; Luke A O'Neill; Dermot Kelleher; Christine E Loscher
Journal:  PLoS Pathog       Date:  2011-06-30       Impact factor: 6.823

10.  Salmonella-induced mucosal lectin RegIIIβ kills competing gut microbiota.

Authors:  Christian Stelter; Rina Käppeli; Claudia König; Alexander Krah; Wolf-Dietrich Hardt; Bärbel Stecher; Dirk Bumann
Journal:  PLoS One       Date:  2011-06-09       Impact factor: 3.240

View more
  68 in total

1.  Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage.

Authors:  Mizuho Hasegawa; Shoko Yada; Meng Zhen Liu; Nobuhiko Kamada; Raúl Muñoz-Planillo; Nhu Do; Gabriel Núñez; Naohiro Inohara
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  The role of Gr-1(+) cells and tumour necrosis factor-α signalling during Clostridium difficile colitis in mice.

Authors:  Andrew J McDermott; Kathryn E Higdon; Ryan Muraglia; John R Erb-Downward; Nicole R Falkowski; Roderick A McDonald; Vincent B Young; Gary B Huffnagle
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

Review 3.  Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns.

Authors:  E G Pamer
Journal:  Mucosal Immunol       Date:  2014-01-08       Impact factor: 7.313

4.  Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection.

Authors:  Michael C Abt; Brittany B Lewis; Silvia Caballero; Huizhong Xiong; Rebecca A Carter; Bože Sušac; Lilan Ling; Ingrid Leiner; Eric G Pamer
Journal:  Cell Host Microbe       Date:  2015-07-08       Impact factor: 21.023

5.  Is Clostridium difficile infection a risk factor for subsequent bloodstream infection?

Authors:  Robert J Ulrich; Kavitha Santhosh; Jill A Mogle; Vincent B Young; Krishna Rao
Journal:  Anaerobe       Date:  2017-06-29       Impact factor: 3.331

Review 6.  The intestinal microbiota and susceptibility to infection in immunocompromised patients.

Authors:  Ying Taur; Eric G Pamer
Journal:  Curr Opin Infect Dis       Date:  2013-08       Impact factor: 4.915

Review 7.  Regulation of the immune system by the resident intestinal bacteria.

Authors:  Nobuhiko Kamada; Gabriel Núñez
Journal:  Gastroenterology       Date:  2014-02-04       Impact factor: 22.682

8.  Role of GM-CSF in the inflammatory cytokine network that regulates neutrophil influx into the colonic mucosa during Clostridium difficile infection in mice.

Authors:  Andrew J McDermott; Charles R Frank; Nicole R Falkowski; Roderick A McDonald; Vincent B Young; Gary B Huffnagle
Journal:  Gut Microbes       Date:  2014-07-21

Review 9.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

Review 10.  Clostridium difficile colitis: pathogenesis and host defence.

Authors:  Michael C Abt; Peter T McKenney; Eric G Pamer
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.